Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture

新型咪唑四嗪可逃避已知的耐药机制，并在细胞培养中有效对抗替莫唑胺耐药的脑癌